Recent news on Nexavar

Analysis: Street doubts Neurochem's drug  -  25 May 2007
Science Daily (press release)Analysis: Analysts split on Onyx's Nexavar (February 14, 2007) -- Onyx rises and falls on its drug Nexavar, but analysts are split on the potential of the

Doctor hits out at NHS drugs policy  -  25 May 2007
The Northern Echo,But he is also concerned at restrictions placed on other new drugs, such as the kidney cancer drugs Sutent and Nexavar, which are widely available abroad,

Onyx Pharmaceuticals (ONXX) Lower on Nexavar ASCO Talk  -  May 23, 2007
StreetInsider.com (subscription),StreetInsider.com provides up-to-the-minute active trading news and information. Only the most relevant news makes it through to our members, and only what

Biotech Bonanza: What to Watch at ASCO  -  May 10, 2007
TheStreet.comIn February, Onyx and partner Bayer announced the early stoppage of their phase III Nexavar liver cancer study after an interim analysis found patients

Sisters in fight for cancer drug  -  May 9, 2007
BBC News,Daughters Kate Spall and Emma Northcott interrupted a board meeting of Conwy and Denbighshire NHS Trust to demand Nexavar, available in parts of England.

DRUG WIN TOO LATE  -  May 17, 2007
Mirror.co.uk,Hazel Watts, 66, has kidney cancer and her consultant recommended Nexavar in June last year. But Devon Primary Care Trust said it was not listed for

Cancer drug trial follows protest  -  May 10, 2007
BBC News,Her two daughters interrupted a NHS trust meeting on Tuesday to demand she was given the drug Nexavar, which can help slow the progress of the tumour.

Cancer gran Hazel wins the fight for drug  -  May 14, 2007
Exmouth Herald,After a top cancer specialist supported Hazel's plea to be allowed to try tumour-shrinking drug Nexavar, a PCT appeal panel yesterday reviewed Mrs Watt's

Drug trial patient making progress  -  May 17, 2007
Redditch Advertiser,Bryan Baldwin, from Church Hill, was diagnosed with incurable renal cancer last June and told he would not receive funding for the drug Nexavar,

Germany's Bayer says top drug sales rise in Q1  -  May 8, 2007
ReutersBayer hoped that Nexavar, which had sales of 130 million euros last year, could reach 1 billion euros in sales if it gets approvals for treatment for

Cancer woman wins new drug plea  -  May 2, 2007
BBC News,Hazel Watts, 66, of Budleigh Salterton, was told that a new drug Nexavar could extend her life by up to two years. But Devon Primary Care Trust (PCT) said

Fund life-preserving drugs: cancer survivor  -  Apr 26, 2007
Mississauga News,Clark, co-founder of the Kidney Cancer Support Group, can't understand why a drug that has helped him beat the odds of survival, called Nexavar,

Onyx Pharmaceuticals Announces First Quarter 2007 Financial ...  -  May 2, 2007
PR Newswire (press release),The company is developing Nexavar(R), a small molecule drug, with Bayer Pharmaceuticals Corporation. Nexavar has been approved for the treatment of advanced

Round one win!  -  May 2, 2007
Exmouth Journal,Now a health chief's decision not to allow cancer sufferer Hazel Watts to have tumour-shrinking Nexavar is to be reviewed. Hazel, 66, of Clinton Close,

Dying cancer woman wins drug appeal  -  May 2, 2007
Channel 4 News,It is understood that Mrs Watts had been taking a course of interferon and painkillers and was told by the PCT earlier this year that Nexavar had not been

Appeal hope for drug fight gran  -  May 2, 2007
Midweek Herald,Now a health chief's decision not to allow cancer sufferer Hazel Watts to have tumour-shrinking Nexavar is to be reviewed.

Community aids single mother  -  May 1, 2007
Outer Banks Sentinel,The drug, called Nexavar, was developed by Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals Incorporated. Nexavar has been categorized by those in

Onyx Phermaceuticals To Present At Morgan Stanley Global Healthcare  -  Apr 30, 2007
WebWire (press release),The company is developing Nexavar®, a small molecule drug, with Bayer Pharmaceuticals Corporation. Nexavar has been approved for the treatment of advanced

New Report: Unmanaged, Diabetes Drug Costs Could Surge Nearly 70 ...  -  May 17, 2007
PR Newswire (press release),Rapid adoption of new, higher cost therapies, such as Nexavar(R), Revlimid(R) and Sutent(R), contributed to the sharp increase in the average cost of

Diabetes Drug Spending May Surge 70% by 2010, Cancer Now Drives ...  -  May 17, 2007
SeniorJournal.com,Rapid adoption of new, higher cost therapies, such as Nexavar, Revlimid and Sutent, contributed to the sharp increase in the average cost of treatment.

Zacks Bull and Bear of the Day Highlights: Bayer AG, Enzon ...  -  May 10, 2007
Business Wire (press release),The HealthCare division continues to improve its margins and Levitra and Yasmin continue to grow in double digits while its cancer drug, Nexavar should

Will there soon be a cure for everything?  -  May 1, 2007
Belfast Telegraph,Other drugs in the pipeline include Tykerb for breast cancer and Sutent and Nexavar for kidney cancer, which will also work on a range of more common

Fund life-preserving drugs: cancer survivor  -  26 Apr 2007
Mississauga News,Clark, co-founder of the Kidney Cancer Support Group, can't understand why a drug that has helped him beat the odds of survival, called Nexavar,

Bayer First-Quarter Net Surges on Schering Purchase (Update8)  -  26 Apr 2007
BloombergBayer is depending on steady sales from Betaseron and Yasmin as revenue from its new treatments like cancer drug Nexavar kicks in.

US biotech drug spending rises while Congress debates over ...  -  26 Apr 2007
BiopharmaReporter.com,Revlimid (lenalidomide) for multiple myeloma and Pfizer's Sutent (sunitinib) and Bayer and Onyx' Nexavar (sorafenib), both used for kidney cancer.

Biotech Drug Spending Increases 21 Percent Even as Growth in Rx ...  -  26 Apr 2007
dBusinessNews St. Louis (press release),...increase in spending at 39.5 percent, which was driven by new treatments including three new drugs introduced in 2006 (Nexavar®, Revlimid® and Sutent®).

Wyeth's Torisel May Be Latest Cancer Drug to Win FDA Approval  -  Apr 3, 2007
BloombergTorisel may join Pfizer Inc.'s Sutent and Bayer AG's Nexavar as the first drugs in two decades to fight the disease effectively, doctors say.

Fears grandmother has fallen victim to ‘postcode lottery’  -  Apr 12, 2007
Devon 24,The PCT said the decision not to pay £3000 a month for Mrs Watts to receive Nexavar, a drug which shrinks tumours by cutting off their blood supply,

Wyeth Faces Delay in US Approval of Cancer Drug (Update1)  -  Apr 6, 2007
BloombergTorisel would join Pfizer Inc.'s Sutent and Bayer AG's Nexavar as the first drugs in two decades to effectively hold off incurable kidney cancer,

Family fight bureaucracy for father's cancer  -  Apr 11, 2007
Blyth Wansbeck Today,Ken, a worker at Blyth Fire Station, needs the drugs Nexavar or Sutent – both of which are used in other parts of the country, but are so expensive they are

FDA Delays Decision on Wyeth Drug  -  Apr 6, 2007
TheStreet.comThe FDA approved Nexavar from Onyx Pharmaceuticals (ONXX - Cramer's Take - Stockpickr) and Bayer (BAY - Cramer's Take - Stockpickr) in December 2005.

Cancer gran denied drug  -  Apr 4, 2007
Exmouth Journal,Mrs Watts' consultant at the Royal Devon and Exeter Hospital has recommended she is given the new drug - Nexavar. Research shows it shrinks tumours by

Controversial NHS 'top up' scheme is launched  -  Apr 25, 2007
Daily Mail,Ten drugs so far are on the list, including Avastin for bowel cancer, Alimta for lung cancer, kidney cancer drugs Nexavar and Sutent, and Velcade for

Japan seen as market for molecular target drugs  -  Mar 29, 2007
The Daily Yomiuri,Both Nexavar and Sunitinib are molecular target drugs. Foreign-affiliated companies are increasingly aggressive in their efforts to market these new types

‘Help mum to live’  -  Mar 30, 2007
Exmouth Herald,Mrs Watts' consultant at the Royal Devon and Exeter Hospital has recommended she is given the drug - Nexavar - which shrinks tumours by starving their blood

Onyx Pharma: Risky business  -  Apr 2, 2007
Blogging StocksClinical trials of its drug Nexavar, a treatment for liver cancer, have gone well. And the company benefited from a narrowing of its loss in the fourth

WeissComm Partners Announces Several New Hires to Strengthen and ...  -  Apr 23, 2007
PR Newswire (press release),...supporting the FDA approval and launch of Bayer HealthCare Pharmaceuticals' and Onyx Pharmaceuticals' advanced kidney cancer treatment, Nexavar(R).

Idera Pharmaceuticals Announces Presentations of Preclinical Data ...  -  Apr 18, 2007
PharmaLive.com (press release),Idera disclaims any intention or obligation to update any forward-looking statements. Nexavar(R) is a registered trademark of Onyx Pharmaceuticals and Bayer

Cyclacel Pharmaceuticals CEO Speaks About His Company  -  Apr 16, 2007
Seeking Alpha,At the same time it targets a mechanism also targeted by some recently approved, anti-cancer drugs -called Avastin and Nexavar. That target is called VEGFR2

Welsh patients may get new drugs faster  -  Apr 6, 2007
ic Wales,But even if the AWMSG decides that the drugs should be available on the NHS - it turned down another kidney cancer drug, Nexavar last month - if Nice

Idera Pharmaceuticals Announces Presentations of Preclinical Data ...  -  Apr 19, 2007
PipelineReview.com (press release),...and the multikinase inhibitor sorafenib tosylate (Nexavar®) demonstrates enhanced antitumor activity in a human non-small cell lung cancer xenograft

Cancer gran's life-hope journey  -  Apr 18, 2007
Exmouth Journal,Her appointment in Bristol is vital if she is to have a chance to appeal against Devon Primary Care Trust's decision not to fund cancer drug Nexavar - which

Ascenta Therapeutics Highlights Multiple Data Presentations at ...  -  Apr 13, 2007
Genetic Engineering News (press release),...sorafenib Therapeutics (Nexavar(R)) --------- --------- ---------------------------------- -------------- Tuesday 3:30pm Preclinical characterization of

Setback for Wyeth as FDA delays review on kidney cancer drug Torisel  -  Apr 10, 2007
Pharma Times (subscription),...it will come up against two recently-approved drugs for renal cell carcinoma, namely Pfizer's Sutent (sunitinib) and Bayer/Onyx' Nexavar (sorafenib) and

$391 margin of victory in stock game  -  Apr 8, 2007
The News-Press,The company manufactures a drug, Nexavar, which has exceeded expectations in clinical trials with patients with advanced liver cancer.

Overhauling clinical trials  -  Apr 5, 2007
Nature.com (subscription),...who helped design the trials that sampled Bayer's small molecule Nexavar (sorafenib) in multiple tumor types before settling on kidney cancer.

Bayer wins bid deal for Schering's US subsidiary  -  Apr 5, 2007
Newark Star Ledger,Bayer has a promising drug for kidney cancer, Nexavar, that it plans to expand to other treatment categories, and, has emerged as "partner of choice" for

Biotech Survives a Rocky Quarter on the Capital Markets  -  Apr 5, 2007
Drug Newswire (press release),The jump was due to an announcement that it was prematurely halting a clinical trial testing Nexavar in advanced liver cancer, based on an interim review of

VioQuest Pharmaceuticals Adds Two New Products to Its Pipeline  -  Mar 30, 2007
PharmaLive.com (press release),In addition, HFS is being seen in patients receiving some of the newer tyrosine kinase class of therapies sorafenib (Nexavar(TM)).

Premarket Movers: Lennar Dips, Vyyo Up  -  Mar 28, 2007
Houston Chronicle,Analyst Jim Reddoch said buyout speculation and opportunities for Onyx's drug Nexavar as a liver cancer treatment have taken the stock price above its

Bid for cancer drug turned down  -  27 Mar 2007
Channel 4 News,Nine primary care trusts around England have agreed to fund treatment with Sutent, which is widely used in Europe and America, or a similar drug, Nexavar.

Nexavar (sorafenib) - the latest weapon in the fight against cancer  -  Mar 20, 2007
ic Wales,What is it for: Used in the treatment of patients with advanced renal cell cancer when standard therapy has not helped to stop the disease or is considered

The little biotech company that could Onyx finds success with ...  -  Mar 22, 2007
San Francisco Chronicle,In February, Onyx said Nexavar apparently extended the survival of liver cancer patients in a clinical trial. Its share price nearly doubled to $24.

The Success of Cancer Drug Nexavar May Soon End Clinical Trials  -  Mar 16, 2007
TopCancerNews.com,It is estimated that 16780 people in the United States will die from liver cancer in 2007 -- and it seems Nexavar, a drug initially predicted to fail when

Bayer has high hopes that cancer drug Nexavar will be huge  -  Mar 16, 2007
Pharma Times (subscription),However most excitement was reserved for the performance of Nexavar (sorafenib), which is currently approved as a treatment for advanced kidney cancer,

Biotech Weathers a Market Storm in February  -  Mar 23, 2007
Drug Newswire (press release),Nexavar net revenue, as recorded by Bayer, was $165.0 million for the year ended December 31, 2006. Onyx's shares finished February up a whopping 122% more

Anger as new drug rejected on grounds of cost  -  Mar 21, 2007
ic Wales,The drug Nexavar will not be available on the NHS in Wales, even though research has found it can extend patients' lives. There are few other effective

Natural drugs undervalued in drug discovery  -  Mar 21, 2007
DrugResearcher.com,The drug the authors are referring to is Onyx's Nexavar (sorafenib), which was developed in conjunction with Bayer. The compound inhibits multiple kinases

Onyx Pharmaceuticals to Present at Lehman Global Healthcare Conference  -  Mar 16, 2007
PharmaLive.com (press release),The company is developing Nexavar(R), a small molecule drug, with Bayer Pharmaceuticals Corporation. Nexavar has been approved for the treatment of advanced

Sign For Kidney Cancer Drug  -  Mar 16, 2007
Pembrokeshiretv.com,Leading cancer consultants agree that Sutent & Nexavar represent the first real advance in treatment for a hitherto almost untreatable cancer.

Keith wins cancer cash fight  -  Feb 28, 2007
Clitheroe Today,Keith Ditchfield (53), from Stonyhurst, has secured funding for Nexavar, which he had been forced to buy over the internet from Germany at a cost of £3000

Experts back plea for cancer drugs  -  Feb 26, 2007
The Northern Echo,The experts, drawn from elite cancer centres from across the UK, want to see Sutent, also known as sunitinib, and Nexavar, also known as sorafenib,

Minister says 'no' to cancer drug plea  -  Mar 9, 2007
The Northern Echo,Despite an explicit recommendation from the UK's leading organisation of kidney cancer experts that Sutent - and a similar drug called Nexavar - should be

Bayer profit soars past projections  -  Mar 15, 2007
Pittsburgh Post Gazette,...an oral contraceptive produced by Schering; Levitra, Bayer's erectile dysfunction drug; and Nexavar, a cancer drug introduced last year.

Wall Street's Wish List  -  Feb 27, 2007
Motley Fool12, Onyx and partner Bayer (NYSE: BAY) announced strong results for its drug Nexavar when used to treat liver cancer. How much do you want to bet that the

Onyx Pharmaceuticals Announces Presentation At Cowen Health Care ...  -  Mar 8, 2007
WebWire (press release),The company is developing Nexavar®, a small molecule drug, with Bayer Pharmaceuticals Corporation. Nexavar has been approved for the treatment of advanced

Bayer says 4Q profit surges to $410M  -  Mar 15, 2007
The Westfall Weekly News,Other drugs, including Betaferon and the cancer drug Nexavar, lifted the results. The company‘s crop sciences unit posted fourth-quarter sales of 1.3

Cancer victims denied wonder drugs  -  Feb 28, 2007
Norwich Evening News,The drugs, Sutent and Nexavar, have been proven to shrink tumours dramatically, with some disappearing altogether. However the National Institute for Health

Dismay as healthcare chiefs react  -  Feb 27, 2007
The Northern Echo,Yesterday, The Northern Echo revealed that the UK's foremost specialists in kidney cancer have recommended that new drugs Sutent and Nexavar should be made

Man wins fight with NHS for free cancer treatment  -  Feb 26, 2007
ic CheshireOnline,The 53-year-old’s bid to get Nexavar on the NHS was rejected and he spent £3000 a month buying the drug himself, but yesterday he revealed the state has

Native kinase profiling  -  Mar 21, 2007
DrugResearcher.com,The problems involved in designing effective inhibitors are highlighted by the recent failure of Onyx' and Bayer's Nexavar (sorafenib) in a skin cancer

Global pharmaceutical sales up 7 pct in '06-report  -  Mar 20, 2007
ReutersN: Quote, Profile, Research) Sutent, and Nexavar from Bayer AG (BAYG.DE: Quote, Profile, Research) and Onyx Pharmaceuticals Inc. (ONXX.

Global Pharmaceutical Sales Up 7 Pct in '06-Report  -  Mar 20, 2007
Reuters.uk,N: Quote, Profile , Research) Sutent, and Nexavar from Bayer AG (BAYG.DE: Quote, Profile , Research) and Onyx Pharmaceuticals Inc. (ONXX.

Pfizer's a Sell: Shrinking Top Line, No Blockbusters In the Pipeline  -  Mar 22, 2007
Seeking Alpha,This data should establish Sutent as the clear first-line choice for patients, relegating Onyx and Bayer s Nexavar to second-line therapy.

Global pharmaceutical sales up 7 pct in '06-report  -  Mar 20, 2007
Financial Express,Recently launched products such as Pfizer Inc.'s Sutent, and Nexavar from Bayer AG and Onyx Pharmaceuticals Inc. helped sales, as did newly approved uses or

NHS won't pay for sight-saving drug  -  Mar 20, 2007
ic Wales,...comes as it emerged that the All Wales Medicine Strategy Group has decided not to authorise the kidney cancer drug Nexavar for use on the NHS.

Zacks Analyst Blog Highlights: Bayer AG and Jones Soda.  -  Mar 20, 2007
Business Wire (press release),...including Levitra, Yasmin, and Kogenate , continue be in the double digits while its cancer drug, Nexavar should help growth continue in 2007.

Bayer Fourth-Quarter Net Jumps on Purchased Drugs (Update5)  -  Mar 15, 2007
BloombergBayer is depending on steady sales from Betaseron and Yasmin as revenue from its new treatments like cancer drug Nexavar kicks in.

Bayer Q4 earnings surge on strong growth in health care, annual ...  -  Mar 15, 2007
Canada.com,...a key competitor to Pfizer Inc.'s Viagra improved 21 per cent. Other drugs, including Betaferon and the cancer drug Nexavar, lifted the results.

Bayer Fourth-Quarter Profit Surges on Schering (Update1)  -  Mar 15, 2007
BloombergBayer is depending on steady sales from Betaseron and Yasmin as revenue from its new cancer drug Nexavar kicks in. The company's crop chemicals unit

2006 a Record Year for Bayer  -  Mar 15, 2007
PharmaLive.com (press release),...“Our cancer drug Nexavar® turned in a particularly encouraging performance, posting sales of EUR 130 million in the year of its introduction,� Wenning

Health group rejects cancer patient's plea for wonder drug  -  Mar 6, 2007
The Northern Echo,...week in The Northern Echo, that Sutent and a similar drug called Nexavar should be made routinely available for the treatment of advanced kidney cancer.

Drug firm a wise choice  -  Mar 4, 2007
The News-Press,12, the California-based company announced the drug it has developed with Bayer, Nexavar, had exceeded expectations in clinical trials with patients with

Know Your Drug Stock ABCs: Part 2  -  Mar 1, 2007
Motley FoolIn order for a clinical trial to be considered successful, Onyx has to show that patients who took its Nexavar cancer therapy survived longer than those who

TXU Corp. Options Trading Surged Before Buyout Was Reported  -  Feb 26, 2007
BloombergThis month, options volume on Onyx Pharmaceuticals Inc. surged before the company said a trial of its Nexavar cancer drug was successful.

New BIO Survey Counters Claims Regarding Single Source Therapies ...  -  Feb 26, 2007
Insurance News Net,For example, neither drugstore.com nor Costco offered advanced, targeted cancer treatments (Sutent, Nexavar, and Sprycel) which were all found on every PDP

'New wonder drug could be our only hope'  -  Feb 26, 2007
The Northern Echo,That is why he has pledged to support the Kidney Cancer UK charity in its efforts to increase access to Sutent and a similar drug, called Nexavar.

Medical Management of Patients With Head and Neck Cancer  -  Mar 1, 2007
Medscape (subscription)Study of the biologic effects of sorafenib (Nexavar, Bay 43-9006) on tumor survival pathways and angiogenesis in patients with recurrent and/or metastatic

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional